Einträge von Buchholz, Stefan auf dem Publikationsserver

Werner-Klein, Melanie, Grujovic, Ana, Irlbeck, Christoph, Obradović, Milan, Hoffmann, Martin, Koerkel-Qu, Huiqin, Lu, Xin, Treitschke, Steffi, Köstler, Cäcilia, Botteron, Catherine, Weidele, Kathrin, Werno, Christian, Polzer, Bernhard, Kirsch, Stefan , Gužvić, Miodrag, Warfsmann, Jens, Honarnejad, Kamran, Czyz, Zbigniew, Feliciello, Giancarlo, Blochberger, Isabell, Grunewald, Sandra, Schneider, Elisabeth, Haunschild, Gundula, Patwary, Nina, Guetter, Severin, Huber, Sandra, Rack, Brigitte, Harbeck, Nadia, Buchholz, Stefan, Rümmele, Petra, Heine, Norbert, Rose-John, Stefan und Klein, Christoph A. (2020) Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency. Nature Communications 11, S. 4977.

Wege, Anja Kathrin, Chittka, Dominik, Buchholz, Stefan, Klinkhammer-Schalke, Monika, Diermeier-Daucher, Simone, Zeman, Florian, Ortmann, Olaf und Brockhoff, Gero (2018) HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women. Breast Cancer Research 20 (1), S. 1-15.

Francis, Prudence A. , Pagani, Olivia, Fleming, Gini F., Walley, Barbara A., Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo, Ciruelos, Eva, Burstein, Harold J., Bonnefoi, Hervé R., Bellet, Meritxell, Martino, Silvana, Geyer, Charles E., Goetz, Matthew P., Stearns, Vered, Pinotti, Graziella, Puglisi, Fabio , Spazzapan, Simon, Climent, Miguel A., Pavesi, Lorenzo, Ruhstaller, Thomas, Davidson, Nancy E., Coleman, Robert, Debled, Marc, Buchholz, Stefan, Ingle, James N., Winer, Eric P., Maibach, Rudolf, Rabaglio-Poretti, Manuela, Ruepp, Barbara, Di Leo, Angelo , Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron und Regan, Meredith M. (2018) Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England Journal of Medicine 379 (2), S. 122-137. Volltext nicht vorhanden.

König, Julia, Schmid, Sabine, Löser, Eva, Neumann, Olaf, Buchholz, Stefan und Kästner, Ralph (2016) Interplay of demographic variables, birth experience, and initial reactions in the prediction of symptoms of posttraumatic stress one year after giving birth. European Journal of Psychotraumatology 7 (1), S. 32377. Volltext nicht vorhanden.

Francis, Prudence A. , Regan, Meredith M., Fleming, Gini F., Láng, István, Ciruelos, Eva , Bellet, Meritxell, Bonnefoi, Hervé R., Climent, Miguel A., Da Prada, Gian Antonio, Burstein, Harold J., Martino, Silvana, Davidson, Nancy E., Geyer, Charles E., Walley, Barbara A., Coleman, Robert, Kerbrat, Pierre, Buchholz, Stefan, Ingle, James N., Winer, Eric P., Rabaglio-Poretti, Manuela, Maibach, Rudolf, Ruepp, Barbara, Giobbie-Hurder, Anita, Price, Karen N., Colleoni, Marco, Viale, Giuseppe, Coates, Alan S., Goldhirsch, Aron und Gelber, Richard D. (2015) Adjuvant Ovarian Suppression in Premenopausal Breast Cancer. New England Journal of Medicine 372 (5), S. 436-446. Volltext nicht vorhanden.

Knop, Janin, Hanses, Frank, Leist, Teresa, Archin, Nancie M., Buchholz, Stefan, Gläsner, Joachim, Gessner, André und Wege, Anja K. (2015) Staphylococcus aureusInfection in Humanized Mice: A New Model to Study Pathogenicity Associated With Human Immune Response. Journal of Infectious Diseases 212 (3), S. 435-444. Volltext nicht vorhanden.

Werner-Klein, Melanie, Proske, Judith, Werno, Christian, Schneider, Katharina, Hofmann, Hans-Stefan, Rack, Brigitte, Buchholz, Stefan, Ganzer, Roman, Blana, Andreas, Seelbach-Göbel, Birgit, Nitsche, Ulrich, Männel, Daniela N. und Klein, Christoph A. (2014) Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients. PLoS ONE 9 (5), e97860.

Diller, Magnus, Schüler, Susanne, Buchholz, Stefan, Lattrich, Claus, Treeck, Oliver und Ortmann, Olaf (2014) Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines. Maturitas 77 (4), S. 336-343. Volltext nicht vorhanden.

Seitz, Stephan, Buchholz, Stefan, Schally, Andrew Victor, Weber, Florian, Klinkhammer-Schalke, Monika, Inwald, Elisabeth C, Perez, Roberto, Rick, Ferenc G, Szalontay, Luca, Hohla, Florian, Segerer, Sabine, Kwok, Chui Wai, Ortmann, Olaf und Engel, Jörg Bernhard (2014) Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. BMC Cancer 14 (1). Volltext nicht vorhanden.

Donders, Gilbert, Neven, Patrick, Moegele, Maximilian, Lintermans, Anneleen, Bellen, Gert, Prasauskas, Valdas, Grob, Philipp, Ortmann, Olaf und Buchholz, Stefan (2014) Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Research and Treatment 145 (2), S. 371-379. Volltext nicht vorhanden.

Machleidt, Anna, Buchholz, Stefan, Diermeier-Daucher, S., Zeman, Florian, Ortmann, Olaf und Brockhoff, Gero (2013) The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients. BMC Cancer 13.

Seitz, Stephan, Buchholz, Stefan, Schally, Andrew V. , Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf und Hohla, Florian (2013) Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]. Anti-Cancer Drugs 24 (2), S. 150-157. Volltext nicht vorhanden.

Rick, Ferenc G. , Buchholz, Stefan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L. und Hohla, Florian (2012) Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers. Cell Cycle 11 (13), S. 2518-2525. Volltext nicht vorhanden.

Rick, Ferenc G. , Seitz, Stephan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L. und Hohla, Florian (2012) GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer. Cell Cycle 11 (22), S. 4203-4210. Volltext nicht vorhanden.

Diermeier-Daucher, Simone, Ortmann, Olaf, Buchholz, Stefan und Brockhoff, Gero (2012) Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signaling. mAbs 4 (5), S. 614-622. Volltext nicht vorhanden.

Diermeier‐Daucher, Simone, Breindl, Stefanie, Buchholz, Stefan, Ortmann, Olaf und Brockhoff, Gero (2011) Modular anti‐EGFR and anti‐Her2 targeting of SK‐BR‐3 and BT474 breast cancer cell lines in the presence of ErbB receptor‐specific growth factors. Cytometry Part A 79A (9), S. 684-693. Volltext nicht vorhanden.

Lux, Michael P. , Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt und Schneeweiss, Andreas (2010) Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System. Onkologie 33 (4), S. 155-166. Volltext nicht vorhanden.

Juhasz-Böss, Ingolf, Hofele, Antje, Lattrich, Claus, Buchholz, Stefan, Ortmann, Olaf und Malik, Eduard (2010) Matrix metalloproteinase messenger RNA expression in human endometriosis grafts cultured on a chicken chorioallantoic membrane. Fertility and Sterility 94 (1), S. 40-45. Volltext nicht vorhanden.

Hohla, Florian, Buchholz, Stefan, Schally, Andrew V. , Krishan, Awtar, Rick, Ferenc G. , Szalontay, Luca, Papadia, Andrea , Halmos, Gabor, Koster, Frank, Aigner, Elmar, Datz, Christian und Seitz, Stephan (2010) Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells. Cancer Letters 294 (1), S. 35-42. Volltext nicht vorhanden.

Hohla, Florian, Buchholz, Stefan, Schally, Andrew V , Seitz, Stefan, Rick, Ferenc G. , Szalontay, Luca, Varga, Jozsef L., Zarandi, Marta, Halmos, Gabor, Vidaurre, Irving, Krishan, Awtar, Kurtoglu, Metin, Chandna, Sudhir , Aigner, Elmar und Datz, Christian (2009) GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cell Cycle 8 (19), S. 3149-3156. Volltext nicht vorhanden.

Seitz, Stephan, Schally, Andrew V. , Treszl, Andrea, Papadia, Andrea , Rick, Ferenc , Szalontay, Luca, Szepeshazi, Karoly, Ortmann, Olaf, Halmos, Gabor, Hohla, Florian und Buchholz, Stefan (2009) Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition. Anti-Cancer Drugs 20 (7), S. 553-558. Volltext nicht vorhanden.

Köster, Frank, Engel, Jörg B. , Schally, Andrew V. , Hönig, Arnd, Schröer, Andreas, Seitz, Stephan, Hohla, Florian, Ortmann, Olaf, Diedrich, Klaus und Buchholz, Stefan (2009) Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition. Breast Cancer Research and Treatment 116 (2), S. 273-279. Volltext nicht vorhanden.

Hohla, Florian, Moder, Angelika, Mayrhauser, Ursula, Hauser-Kronberger, Cornelia, Schally, Andrew , Varga, Jozsef, Zarandi, Marta, Buchholz, Stefan, Huber, Rudolf, Aigner, Elmar, Ritter, Markus und Datz, Christian (2008) Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon. International Journal of Oncology. Volltext nicht vorhanden.

Buchholz, Stefan, Schally, Andrew V. , Engel, Jörg B. , Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L. und Halmos, Gabor (2007) Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proceedings of the National Academy of Sciences 104 (6), S. 1943-1946. Volltext nicht vorhanden.

Buchholz, Stefan, Keller, Gunhild, Schally, Andrew V. , Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin und Engel, Jörg B. (2006) Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations. Proceedings of the National Academy of Sciences 103 (27), S. 10403-10407. Volltext nicht vorhanden.